How Trichomonas steals resources and evades your immune system
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Having had trichomoniasis protects you from almost nothing. About 1 in 5 people are infected again within three months of being treated, and while most of that is reinfection from untreated partners, part of it is that the immune system never builds a proper defence.
Here is what the parasite does to make sure of that.
Related pages: Trichomoniasis
The bottom line
- The parasite releases enzymes that cut human antibodies, including the IgA that protects mucosal surfaces.
- It provokes a heavy influx of neutrophils that causes inflammation without reliably clearing it.
- Infection produces no lasting protective immunity, and reinfection is common.
- Partner treatment is part of the treatment, not an optional extra.
- Why the immune response fails to clear it even with a strong inflammatory response.
- Whether the viruses the parasite carries change how badly people react.
The story, step by step
- 1. Cutting antibodies ()
- 2. Inflaming, not clearing ()
- 3. No memory ()
- 4. Passengers ()
- 5. What beats it ()
What the evidence labels mean
Enzymes that chop your antibodies before they can work
What happens
Mucosal surfaces are defended largely by IgA antibodies, which bind pathogens and stop them attaching.
What the research shows
- T. vaginalis secretes cysteine proteases that cleave human IgA and IgG.
- A cut antibody cannot flag the parasite for destruction.
- The same enzymes damage host cells and degrade other defensive proteins.
- The parasite carries an unusually large number of protease genes.
Why it matters
The immune system's main weapon at this surface is being disassembled as fast as it arrives.
What's still uncertain
- How much antibody degradation matters relative to other evasion tactics is not settled.
Read more
- OwieClear: How it invades the liningOwieClear
Next: Inflaming, not clearing
A big immune response that doesn't finish the job
What happens
The body responds to the parasite by recruiting neutrophils in large numbers.
What the research shows
- Neutrophils are the dominant immune cell in trichomoniasis, and they can kill the parasite in a distinctive way, attacking in groups and taking off pieces of it.
- But the response often fails to eliminate the infection, which can persist for months or years untreated.
- Meanwhile the inflammation itself damages the lining and contributes to symptoms.
- Much of the soreness and discharge is this response rather than the parasite directly.
Why it matters
This is a recurring theme across sexually transmitted infections: the damage people feel is often their own immune system working, and failing.
What's still uncertain
- Why clearance fails despite a vigorous response is unresolved.
Read more
Next: No memory
Why you can get it over and over
What happens
Unlike infections that leave you protected, trichomoniasis leaves little behind.
What the research shows
- There is no reliable protective immunity after infection, and no vaccine.
- About 1 in 5 women are infected again within 3 months of treatment.
- Much of that is reinfection from a partner who was never treated, since most men have no symptoms and are often never tested.
- Retesting at 3 months is recommended for women for exactly this reason.
Why it matters
Reinfection is not a sign that the treatment failed or that anyone did anything wrong. It is the expected pattern when a partner isn't treated.
What's still uncertain
- Distinguishing reinfection from treatment failure requires knowing whether the person was re-exposed, which isn't always possible.
Read more
- CDC: About trichomoniasisGovernment
- OwieClear: Restoring the lining afterwardOwieClear
Next: Passengers
The bacterium and the virus it carries
What happens
The parasite can host other organisms inside itself, which complicates the immune picture.
What the research shows
- Mycoplasma hominis, a bacterium, can live inside the parasite.
- Double-stranded RNA viruses, Trichomonasvirus, infect many strains.
- Virus-carrying strains have been linked to stronger inflammatory responses and to differences in how the parasite handles metronidazole.
- One proposal is that treatment releases viral material, which could contribute to symptoms during or just after treatment.
Why it matters
Two people with the same diagnosis may be carrying genuinely different organisms, which may be part of why experiences differ so much.
What's still uncertain
- This is an active research area, and the idea that treatment-released virus worsens symptoms is a hypothesis rather than an established effect.
Read more
Next: What beats it
What actually works against all this
What happens
Despite the evasion, the parasite has one clear weakness.
What the research shows
- Nitroimidazole drugs, metronidazole and tinidazole, are activated inside the parasite's own hydrogenosomes and destroy its DNA.
- For women, a 7-day course of metronidazole clears the infection more reliably than a single large dose. In a randomized trial, 11% of the 7-day group still had the parasite at the test of cure, against 19% of the single-dose group.
- Resistance exists and is increasing, and persistent infection may need higher doses or longer courses.
- Vaginal metronidazole gel does not cure it and is not adequate treatment.
Why it matters
The immune system may not win this one, but a cheap tablet does, provided it's the right course and partners are treated too.
What's still uncertain
- Resistant infections are difficult to treat and need specialist advice.
- Alcohol must be avoided during and shortly after treatment with these drugs.